Caterpillar Sales Rebates and Discounts increased by 16.5% to $303.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.5%, from $260.00M to $303.00M. Over 5 years (FY 2020 to FY 2025), Sales Rebates and Discounts shows an upward trend with a 14.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may signal higher competitive pressure or changes in payer mix, impacting net realized pricing.
Accrued liabilities representing estimated rebates, chargebacks, and discounts owed to wholesalers, pharmacy benefit man...
Highly specific to the pharmaceutical and healthcare sectors; essential for comparing net pricing power.
sales_rebates_and_discounts| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $143.00M | $159.00M | $253.00M | $260.00M | $303.00M |
| QoQ Change | — | +11.2% | +59.1% | +2.8% | +16.5% |
| YoY Change | — | +11.2% | +59.1% | +2.8% | +16.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.